SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-19-010847
Filing Date
2019-05-28
Accepted
2019-05-28 08:26:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dffn20190522_424b5.htm 424B5 492632
2 dffn20190514_s3img003.gif GRAPHIC 40946
3 dffn20190514_s3img004.gif GRAPHIC 41077
4 logox.jpg GRAPHIC 13617
5 s3img002.jpg GRAPHIC 43900
  Complete submission text file 0001437749-19-010847.txt   686591
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-231541 | Film No.: 19856066
SIC: 2834 Pharmaceutical Preparations